Deborah Heart and Lung Center Introduces the Ivenix Infusion System to the Hospital

Deborah Heart and Lung Center announces its successful hospital-wide go live with Ivenix, a modern smart infusion pump system.

“Though everyone is familiar with IV pump delivery systems used to administer medications during a patient’s hospital stay, improvements in technology have allowed us to do it in a controlled and measured way,” said Rita Zenna, RN, Deborah’s Vice President for Patient Care Services. “This is why we replaced our existing pumps with Ivenix, a state-of-the-art infusion system capable of measuring and controlling medication delivery.”

“Our staff is thrilled with how easy the new pumps are to work with and the enhanced capabilities that are offered,” added Sue Campano, Deborah’s Vice President for Support Services. “Our nurses collaborated extensively when evaluating our choices and ultimately selected Ivenix, a solution they believed would best meet their ability to care for patients.”

“We are enthusiastic about the opportunity to partner with Deborah Heart and Lung Center and bring this innovative infusion system to more clinicians and patients,” said Susan Niemeier, Chief Nursing Officer of Ivenix. “Advancing medication safety and clinical outcomes is critical for a hospital, and we’re honored to support the Deborah Heart’s efforts to protect patient health.”

The Ivenix Infusion System includes a large-volume infusion pump, portfolio of administration sets, and infusion management software with unique capabilities new to the infusion therapy market. Its adaptive fluid delivery reduces flow and accuracy variability to help improve patient safety. Its patient-centered design benefits patients because clinicians spend less time troubleshooting pumps or resolving nuisance alarms, which simplifies infusion delivery for those providing bedside care. Additionally, the Ivenix System can seamlessly integrate with Deborah Heart’s electronic medical record and other hospital information systems, further reducing the possibility of patient medication errors.

“We are excited about how the system is designed to prevent medication errors, reduce nuisance alarms and other common interruptions,” said Zenna. “This will have a significant impact on our ability to provide high-quality care and ensure our patients get the rest needed after surgery.” She added, “We continue to invest in smart technology, and this was a natural next step for us. Our clinical teams are pleased with how smoothly the system was rolled out across the entire hospital.”

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy